Kae Kumagai

Statistics

Publications

Citations

115

H-Index

Active since

2018

Affiliations

Japan Agency for Medical Research and Development(Current)

University of Tsukuba

Tsukuba International University

Kyoto University

Kobe Pharmaceutical University

Kae Kumagai is an author at Japan Agency for Medical Research and Development specializing in life sciences, fibroblast growth factor 21 signaling, and lipid metabolism.

Publications per year

2018–2020

Publications

The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice

Masaya Araki, Yoshimi Nakagawa, Asayo Oishi et al. · International Journal of Molecular Sciences · 2018 · 74 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Enterohepatic Transcription Factor CREB3L3 Protects Atherosclerosis via SREBP Competitive Inhibition

Yoshimi Nakagawa, Yunong Wang, Song‐iee Han et al. · Cellular and Molecular Gastroenterology and Hepatology · 2020 · 24 citations · Full text

Life Sciences, Biochemistry, Pathobiology +16

CREBH Improves Diet-Induced Obesity, Insulin Resistance, and Metabolic Disturbances by FGF21-Dependent and FGF21-Independent Mechanisms

Aoi Satoh, Song‐iee Han, Masaya Araki et al. · iScience · 2020 · 17 citations · Full text

Life Sciences, Endocrinology, Nutritional Sciences +17

1–3 of 3